Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human β-globin gene in hematopoietic cells from homozygous β-thalassemic mice

Mengqun Tan, Keyun Qing, Shangzhen Zhou, Mervin Yoder, Arun Srivastava

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Adeno-associated virus 2 (AAV), a nonpathogenic human parvovirus, has gained attention as a potentially useful vector for human gene therapy. Here, we report successful AAV-mediated stable transduction and high-efficiency, long-term, erythroid lineage-restricted expression of a human β-globin gene in primary murine hematopoietic stem cells in vivo. Bone marrow-derived primitive Sca-1+, lin- hematopoietic stem cells from homozygous β-thalassemic mice were transduced ex vivo with a recombinant AAV vector containing a normal human β-globin gene followed by transplantation into low-dose-irradiated B6.c-kitW41/41 anemic recipient mice. Six months post-transplantation, tail-vein blood samples were analyzed by PCR amplification to document the presence of the transduced human β-globin gene sequences in the peripheral blood cells. Semi-quantitative PCR analyses revealed that the transduced human β-globin gene sequences were present at ∼ 1 copy per cell. The efficiency of the human β-globin gene expression was determined to be up to 35% compared with the murine endogenous β-globin gene by semiquantitative RT-PCR analyses. Peripheral blood samples from several positive recipient mice obtained 10 months posttransplantation were fractionated to obtain enriched populations of granulocytes, lymphocytes, and erythroid cells. PCR analyses revealed the presence of the human β-globin gene sequences in granulocytes and lymphocytes, indicating multilineage reconstitution. However, only the erythroid population was positive following RT-PCR analyses, suggesting lineage-restricted expression of the transduced human β-globin gene. Southern blot analyses of total genomic DNA samples isolated from bone marrow cells from transplanted mice also documented proviral integration. These results provide further support for the potential use of recombinant AAV vectors in gene therapy of β-thalassemia and sickle-cell disease.

Original languageEnglish
Pages (from-to)940-946
Number of pages7
JournalMolecular Therapy
Volume3
Issue number6
DOIs
StatePublished - 2001

Fingerprint

Dependovirus
Globins
Genes
Polymerase Chain Reaction
Hematopoietic Stem Cells
Granulocytes
Genetic Therapy
Transplantation
Lymphocytes
Parvovirus
Erythroid Cells
Thalassemia
Sickle Cell Anemia
Southern Blotting
Bone Marrow Cells
Population
Tail
Veins
Blood Cells
Bone Marrow

Keywords

  • β-globin
  • β-thalassemia
  • Adeno-associated virus
  • Erythroid cell lineage
  • Gene expression
  • Gene therapy
  • Hematopoietic stem/progenitor cells
  • Sickle-cell disease
  • Viral vector

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human β-globin gene in hematopoietic cells from homozygous β-thalassemic mice. / Tan, Mengqun; Qing, Keyun; Zhou, Shangzhen; Yoder, Mervin; Srivastava, Arun.

In: Molecular Therapy, Vol. 3, No. 6, 2001, p. 940-946.

Research output: Contribution to journalArticle

@article{c2d87c42be164841b9bdb3df3b01fff6,
title = "Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human β-globin gene in hematopoietic cells from homozygous β-thalassemic mice",
abstract = "Adeno-associated virus 2 (AAV), a nonpathogenic human parvovirus, has gained attention as a potentially useful vector for human gene therapy. Here, we report successful AAV-mediated stable transduction and high-efficiency, long-term, erythroid lineage-restricted expression of a human β-globin gene in primary murine hematopoietic stem cells in vivo. Bone marrow-derived primitive Sca-1+, lin- hematopoietic stem cells from homozygous β-thalassemic mice were transduced ex vivo with a recombinant AAV vector containing a normal human β-globin gene followed by transplantation into low-dose-irradiated B6.c-kitW41/41 anemic recipient mice. Six months post-transplantation, tail-vein blood samples were analyzed by PCR amplification to document the presence of the transduced human β-globin gene sequences in the peripheral blood cells. Semi-quantitative PCR analyses revealed that the transduced human β-globin gene sequences were present at ∼ 1 copy per cell. The efficiency of the human β-globin gene expression was determined to be up to 35{\%} compared with the murine endogenous β-globin gene by semiquantitative RT-PCR analyses. Peripheral blood samples from several positive recipient mice obtained 10 months posttransplantation were fractionated to obtain enriched populations of granulocytes, lymphocytes, and erythroid cells. PCR analyses revealed the presence of the human β-globin gene sequences in granulocytes and lymphocytes, indicating multilineage reconstitution. However, only the erythroid population was positive following RT-PCR analyses, suggesting lineage-restricted expression of the transduced human β-globin gene. Southern blot analyses of total genomic DNA samples isolated from bone marrow cells from transplanted mice also documented proviral integration. These results provide further support for the potential use of recombinant AAV vectors in gene therapy of β-thalassemia and sickle-cell disease.",
keywords = "β-globin, β-thalassemia, Adeno-associated virus, Erythroid cell lineage, Gene expression, Gene therapy, Hematopoietic stem/progenitor cells, Sickle-cell disease, Viral vector",
author = "Mengqun Tan and Keyun Qing and Shangzhen Zhou and Mervin Yoder and Arun Srivastava",
year = "2001",
doi = "10.1006/mthe.2001.0346",
language = "English",
volume = "3",
pages = "940--946",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human β-globin gene in hematopoietic cells from homozygous β-thalassemic mice

AU - Tan, Mengqun

AU - Qing, Keyun

AU - Zhou, Shangzhen

AU - Yoder, Mervin

AU - Srivastava, Arun

PY - 2001

Y1 - 2001

N2 - Adeno-associated virus 2 (AAV), a nonpathogenic human parvovirus, has gained attention as a potentially useful vector for human gene therapy. Here, we report successful AAV-mediated stable transduction and high-efficiency, long-term, erythroid lineage-restricted expression of a human β-globin gene in primary murine hematopoietic stem cells in vivo. Bone marrow-derived primitive Sca-1+, lin- hematopoietic stem cells from homozygous β-thalassemic mice were transduced ex vivo with a recombinant AAV vector containing a normal human β-globin gene followed by transplantation into low-dose-irradiated B6.c-kitW41/41 anemic recipient mice. Six months post-transplantation, tail-vein blood samples were analyzed by PCR amplification to document the presence of the transduced human β-globin gene sequences in the peripheral blood cells. Semi-quantitative PCR analyses revealed that the transduced human β-globin gene sequences were present at ∼ 1 copy per cell. The efficiency of the human β-globin gene expression was determined to be up to 35% compared with the murine endogenous β-globin gene by semiquantitative RT-PCR analyses. Peripheral blood samples from several positive recipient mice obtained 10 months posttransplantation were fractionated to obtain enriched populations of granulocytes, lymphocytes, and erythroid cells. PCR analyses revealed the presence of the human β-globin gene sequences in granulocytes and lymphocytes, indicating multilineage reconstitution. However, only the erythroid population was positive following RT-PCR analyses, suggesting lineage-restricted expression of the transduced human β-globin gene. Southern blot analyses of total genomic DNA samples isolated from bone marrow cells from transplanted mice also documented proviral integration. These results provide further support for the potential use of recombinant AAV vectors in gene therapy of β-thalassemia and sickle-cell disease.

AB - Adeno-associated virus 2 (AAV), a nonpathogenic human parvovirus, has gained attention as a potentially useful vector for human gene therapy. Here, we report successful AAV-mediated stable transduction and high-efficiency, long-term, erythroid lineage-restricted expression of a human β-globin gene in primary murine hematopoietic stem cells in vivo. Bone marrow-derived primitive Sca-1+, lin- hematopoietic stem cells from homozygous β-thalassemic mice were transduced ex vivo with a recombinant AAV vector containing a normal human β-globin gene followed by transplantation into low-dose-irradiated B6.c-kitW41/41 anemic recipient mice. Six months post-transplantation, tail-vein blood samples were analyzed by PCR amplification to document the presence of the transduced human β-globin gene sequences in the peripheral blood cells. Semi-quantitative PCR analyses revealed that the transduced human β-globin gene sequences were present at ∼ 1 copy per cell. The efficiency of the human β-globin gene expression was determined to be up to 35% compared with the murine endogenous β-globin gene by semiquantitative RT-PCR analyses. Peripheral blood samples from several positive recipient mice obtained 10 months posttransplantation were fractionated to obtain enriched populations of granulocytes, lymphocytes, and erythroid cells. PCR analyses revealed the presence of the human β-globin gene sequences in granulocytes and lymphocytes, indicating multilineage reconstitution. However, only the erythroid population was positive following RT-PCR analyses, suggesting lineage-restricted expression of the transduced human β-globin gene. Southern blot analyses of total genomic DNA samples isolated from bone marrow cells from transplanted mice also documented proviral integration. These results provide further support for the potential use of recombinant AAV vectors in gene therapy of β-thalassemia and sickle-cell disease.

KW - β-globin

KW - β-thalassemia

KW - Adeno-associated virus

KW - Erythroid cell lineage

KW - Gene expression

KW - Gene therapy

KW - Hematopoietic stem/progenitor cells

KW - Sickle-cell disease

KW - Viral vector

UR - http://www.scopus.com/inward/record.url?scp=0034952156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034952156&partnerID=8YFLogxK

U2 - 10.1006/mthe.2001.0346

DO - 10.1006/mthe.2001.0346

M3 - Article

C2 - 11407908

AN - SCOPUS:0034952156

VL - 3

SP - 940

EP - 946

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 6

ER -